Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 4 results.
User Information
Export Records
  1. 1.   High-Mobility Group Nucleosome-Binding Protein 1 as Endogenous Ligand Induces Innate Immune Tolerance in a TLR4-Sirtuin-1 Dependent Manner in Human Blood Peripheral Mononuclear Cells
  2. Arts, Rob J W; Huang, Po-Kai; Yang, De; Joosten, Leo A B; van der Meer, Jos W M; Oppenheim, Joost; Netea, Mihai G; Cheng, Shih-Chin
  3. Frontiers in Immunology. 2018, Mar 14; 9: 526.
  1. 2.   Altered Expression of SHIP, a Toll-like Receptor Pathway Inhibitor, Is Associated With the Severity of Liver Fibrosis in Chronic Hepatitis C Virus Infection
  2. Katsounas, A.; Trippler, M.; Kottilil, S.; Lempicki, R. A.; Gerken, G.; Schlaak, J. F.
  3. Journal of Infectious Diseases. 2011, Oct; 204(8): 1181-1185.
  1. 3.   Induction of in vitro reprogramming by toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: Effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components
  2. Dobrovolskaia, M. A.; Medvedev, A. E.; Thomas, K. E.; Cuesta, N.; Toshchakov, V.; Ren, T. B.; Cody, M. J.; Michalek, S. M.; Rice, N. R.; Vogel, S. N.
  3. Journal of Immunology. 2003 170(1): 508-519.
  1. 4.   Role of p52 (NF-kappa B2) in LPS tolerance in a human B cell line
  2. Wedel, A.; Frankenberger, M.; Sulski, G.; Petersmann, I.; Kuprash, D.; Nedospasov, S.; Ziegler-Heitbrock, H. W. L.
  3. Biological Chemistry. 1999 380(10): 1193-1199.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel